Dongping Tu

A randomized placebo-controlled trial of erlotinib in patients with advanced non-small cell lung cancer (NSCLC) following failure of 1^st line or 2^nd line chemotherapy. A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial

Frances A. Shepherd, José Rodrigues Pereira, Tudor–Eliade Ciuleanu et al. · Journal of Clinical Oncology · 2004 · 262 citations

Ncic Ctg, Pharmacotherapy, Single Agent Activity +16

Identification of novel and conserved microRNAs in Panax notoginseng roots by high-throughput sequencing

Rongchang Wei, Deyou Qiu, Iain W. Wilson et al. · BMC Genomics · 2015 · 43 citations · Full text

Cloning and characterization of squalene synthase and cycloartenol synthase from Siraitia grosvenorii

Huan Zhao, Qi Tang, Changming Mo et al. · Acta Pharmaceutica Sinica B · 2016 · 30 citations · Full text

The Jackknife and Bootstrap.

G. A. Young, Jen-Chung Shao, Dongping Tu · Journal of the Royal Statistical Society Series A (Statistics in Society) · 1996 · 27 citations

J. Shao, Comparative Literature, D. Tu +2

A randomized trial of high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (asct) compared to standard chemo therapy (ct) in women with metastatic breast cancer: a National Cancer Institute of Canada (NCIC) clinical trials group study

Stefan Glück, Michael Crump, D. Stewart et al. · European Journal of Cancer · 2001 · 22 citations

National Cancer Institute, Metastatic Breast Cancer, Breast Oncology +8